ARTICLE SUMMARY:
Cagent Vascular has developed a balloon that uses serration technology to prepare the artery in a more controlled and less traumatic way than conventional balloon angioplasty. The company sees large markets in vessel preparation for above-the-knee applications, and is developing a limb-saving therapy for below-the-knee disease, where there are fewer durable treatment options.
The mainstay of treatment for coronary and peripheral vascular disease—balloon angioplasty—has hardly changed in 40 years, says Carol Burns, CEO of Cagent Vascular.
